Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02802865 · ClinicalTrials.gov registry record · Phase 4
Combined Letrozole and Clomid in Women With Infertility and PCOS
A Phase 4 study, sponsored by Rachel Mejia.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
NCT02802865: Completed Phase 4 study, sponsored by Rachel Mejia.
NCT02802865 is a Phase 4 study that has completed, run by Rachel Mejia. The registered enrollment target is 70 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02802865, a Phase 4 study, has completed, sponsored by Rachel Mejia.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
Study Summary
This study evaluates the addition of clomid to letrozole for the treatment of infertility in women with polycystic ovary syndrome. Half of the participants will receive letrozole and clomid in combination, while the other half will receive letrozole alone.
Primary Outcome
Ovulation: mid-luteal progesterone \> /=3 ng/mL. No ovulation: mid-luteal progesterone \<3ng/mL.
Interventions
- DRUG Letrozole
- DRUG Clomiphene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2016-08 |
| Est. Completion | 2019-02 |
| Phase | Phase 4 |
What the finished NCT02802865 record still lists
NCT02802865 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 2 interventions - of which Letrozole is the first listed.
NCT02802865 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02802865 about?
NCT02802865 is a clinical study titled "Combined Letrozole and Clomid in Women With Infertility and PCOS". This study evaluates the addition of clomid to letrozole for the treatment of infertility in women with polycystic ovary syndrome. Half of the participants will receive letrozole and clomid in combination, while the other half will receive letrozole alone.
What is the current status of trial NCT02802865?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2016-08. Estimated completion is 2019-02.
What interventions are being tested in trial NCT02802865?
The interventions under investigation include: Letrozole (DRUG), Clomiphene (DRUG).
Who is sponsoring clinical trial NCT02802865?
This trial is sponsored by Rachel Mejia, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02802865's enrollment target sits among peer trials
70 1043rd of 2000 higher than 931 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia